Editorial portrait of a woman in her 40s representing women navigating perimenopause and menopause. The image accompanies Dr. Manasvi Bommareddy's menopause and perimenopause care page, which provides evidence-based assessment and individualised treatment options.

MENOPAUSE & PERIMENOPAUSE

Evidence-based care through the menopause transition and beyond

Menopause is more than a change in periods. The transition can affect sleep, mood, energy, cognition, sexual health and physical wellbeing, sometimes gradually and in ways that are difficult to recognise.

Book an appointment

Could your symptoms be Menopause or Perimenopause?

Symptoms during midlife deserve to be understood in context. Not all symptoms occur together and sometimes symptoms have more than one cause. So if something feels different a careful assessment is the first step to understanding why and what the next best step for you is.

Dr.Manasvi is an experienced menopause specialist in Dubai, who uses a comprehehnsive and evidence based approach to put what you are experiencing into context and provide a treatment plan tailored to you.

Book an appointment

Understanding Perimenopause and Menopause

Perimenopause

Perimenopause is the transition leading up to menopause, when changes in ovarian hormone levels can affect menstrual cycles and cause a range of symptoms.

Menopause

Menopause is reached after 12 consecutive months without a menstrual period, when there is no other medical explanation.

Perimenopause can begin several years before the final menstrual period. You don’t need to wait until your periods stop to get evaluated or start treatment

Woman in her 40s representing menopause treatment and care

Treatment Options

There is no single approach to menopause treatment. Your journey is unique, so the treatment plan is tailored specifically to your symptoms, medical history, individual risk factors and preferences.

Hormone replacement therapy

Menopausal Hormone Therapy (HRT)
For women who are suitable candidates, HRT can be highly effective for vasomotor symptoms such as hot flushes and night sweats, and can also improve sleep and other menopause-related symptoms. The choice of oestrogen, progestogen, route and regimen depends on whether you have a uterus, your symptoms, medical history and individual risk factors.

Local Vaginal Oestrogen & Genito-urinary Treatment

Vaginal dryness, burning, discomfort during sex and urinary symptoms may respond particularly well to local treatment. Vaginal oestrogen is a low-dose option for genitourinary symptoms and can be considered separately from systemic HRT. Non-hormonal vaginal moisturisers and lubricants may also be appropriate.

Non-Hormonal & Symptom Specific Treatment

If HRT is not suitable or you prefer not to use hormones, there are evidence-based non-hormonal approaches for symptoms such as hot flushes, sleep disturbance and mood symptoms. Treatment is selected according to the symptoms that are most affecting you and your medical history.

If you are considering HRT, experiencing symptoms of perimenopause or menopause, or would like to discuss your treatment options, book an appointment to explore the approach that is right for you.

Book an appointment

woman in her 40s going through menopause transition focussing on her lifestyle to improve symtoms

Menopause & Long Term Health

Menopause is an important time to look beyond symptom management and consider your longer-term health. Changes in oestrogen levels can lead to changes in bone health, cardiovascular risk, body composition and metabolic health.

Good menopause care therefore looks beyond symptom management to consider your longer-term health, with prevention and early intervention where appropriate.

Book an appointment

Frequently Asked Questions

Perimenopause can begin several years before menopause and may cause changes in periods, sleep, mood, energy, concentration, sexual health and physical wellbeing.

For women over 45, perimenopause can usually be diagnosed clinically based on symptoms and changes in the menstrual cycle. However, symptoms can overlap with other conditions, so a medical assessment is important when the picture is unclear.

Not always. Routine hormone testing is generally not required to diagnose perimenopause in women over 45 with typical symptoms.

Testing may be recommended in particular circumstances, including suspected early menopause or premature ovarian insufficiency, atypical symptoms, or when another medical condition needs to be investigated. Any investigations should be guided by your clinical history and whether the result would change management.

Yes. Perimenopause can begin while periods are still occurring, and some women experience symptoms before their cycles become obviously irregular.

You do not need to wait until your periods stop to seek assessment or discuss treatment. The timing and pattern of your symptoms, together with your menstrual history and overall health, help determine the most appropriate approach.

Yes. For women over 45 with typical symptoms, perimenopause is usually diagnosed clinically rather than through a single hormone blood test.

Hormone levels can fluctuate considerably during the transition, so a result within a laboratory’s reference range does not necessarily exclude perimenopause. Blood tests may nevertheless be appropriate when symptoms are atypical, menopause occurs at a younger age, or another condition needs to be considered.

The first consultation is an assessment rather than a prescription appointment.

Your symptoms, menstrual history, medical history, medications, family history and relevant risk factors are considered before treatment options are discussed. If HRT is appropriate, it may be started following this assessment, but there is no expectation that every woman should take hormone therapy.

HRT describes hormone therapy used to treat symptoms associated with menopause. Some regulated HRT preparations contain hormones that are chemically identical to those produced naturally by the body, often referred to as body-identical HRT.

“BHRT” or “bioidentical hormone replacement therapy” is a broader term and may refer either to regulated preparations or to individually compounded hormone products. Compounded products are not automatically safer or more effective simply because they are described as bioidentical.

When hormone therapy is appropriate, the preparation, dose and route should be selected according to the available evidence, your symptoms, medical history and individual risk factors.

There is no universal yes-or-no answer. For many women, the benefits of HRT outweigh the risks, particularly when treatment is started at an appropriate age and after an individual assessment.

The balance of benefits and risks depends on factors including your age, timing of menopause, symptoms, medical history, family history and the type and route of HRT being considered.

If you have a history of conditions such as breast cancer, blood clots, cardiovascular disease, unexplained vaginal bleeding or liver disease, the decision requires particular care and may require specialist input.

If you have previously been advised that HRT is unsuitable, a specialist assessment may help clarify whether that remains the case and whether there are alternative approaches.

In some circumstances, different formulations or routes of treatment may be considered; in others, non-hormonal treatment may be more appropriate. This depends entirely on the underlying medical history and should be assessed on an individual basis.

Some symptoms may begin to improve within the first few weeks, while others can take longer. Treatment often needs to be reviewed and adjusted according to how you respond and whether side effects occur.

The aim is not simply to prescribe a treatment and leave it unchanged. Ongoing review allows the approach to evolve as your symptoms and circumstances change.

ou do not necessarily need to stop treatment and start again.

Persistent symptoms may relate to the dose, formulation, route of administration, the balance of oestrogen and progesterone, side effects, or another condition occurring alongside menopause. A review can look at your current treatment, symptoms and overall health and determine whether an adjustment or alternative approach would be appropriate.

Yes. Falling oestrogen levels can affect the vaginal and urinary tissues and may contribute to dryness, irritation, discomfort during sex, reduced sexual comfort and urinary symptoms.

These symptoms can be treated and do not necessarily require systemic HRT. Local vaginal oestrogen and other treatments may be appropriate depending on your symptoms and medical history.

Changes in menstrual bleeding are common during perimenopause, but new, heavy, prolonged or unexpected bleeding should not automatically be attributed to menopause.

Bleeding patterns can also change when starting or changing HRT. If bleeding is persistent, heavy, occurs unexpectedly or develops after a period without periods, it should be assessed to determine whether further investigation is required.

Appointment and Enquiries

Contact the Clinic
For general enquiries, clinic information or assistance with appointments, contact GMC Clinics by phone or WhatsApp.

For non-urgent enquiries you may email Dr. Manasvi at ” drmanasvibommareddy@gmail.com”. Please do not use email or WhatsApp for urgent medical concerns or emergencies.